GLP-1 Medications and Thyroid Cancer: What the Evidence Actually Shows
Introduction: The Warning That Worries Millions Open any GLP-1 medication guide — whether for Ozempic, Wegovy, Mounjaro, or Zepbound — and you will encounter the same ominous language: a black box warning about thyroid C-cell tumors. It is the FDA’s strongest safety warning, reserved for drugs with serious or life-threatening risks. For the millions of people now taking these medications for diabetes and weight loss, this warning raises an unsettling question: Am I trading obesity for cancer? ...